Related Experiment Videos
Cancer biotherapy: when, why and how long?
Cancer Biotherapy & Radiopharmaceuticals
|June 14, 2000
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Growth of tumor-derived activated T cells for the treatment of advanced cancer.
Cancer biotherapy & radiopharmaceuticals·2000
A phase I and pharmacokinetic study of CBT-1 as a multidrug resistance modulator in the treatment of patients with advanced cancer.
Cancer biotherapy & radiopharmaceuticals·2000
A revolution in the treatment of non-Hodgkin's lymphoma.
Cancer biotherapy & radiopharmaceuticals·2000
Phase I study of CBT-1 and Taxol in patients with Taxol resistant cancers.
Cancer biotherapy & radiopharmaceuticals·2000
Chemo-biotherapy with 5-fluorouracil, leucovorin, and alpha interferon in metastatic carcinoma of the colon--a Cancer Biotherapy Research Group [CBRG] phase II study.
Cancer biotherapy & radiopharmaceuticals·2000
Long-term survival after continuous infusion interleukin-2.
Cancer biotherapy & radiopharmaceuticals·1997
Personalized Radionuclide Therapy via Avidin-Biotin Pretargeting: Biodistribution and Dosimetry of 177Lu-DOTA-biotin with AvidinOX™ in Solid Tumors.
Cancer biotherapy & radiopharmaceuticals·2026
Neural Decoding of Ultrasound-Modulated Pain States via Deep Learning: Insights from Functional Magnetic Resonance Imaging Data.
Cancer biotherapy & radiopharmaceuticals·2026
Review of Glypican-3-Targeted Imaging Agents for Hepatocellular Carcinoma.
Cancer biotherapy & radiopharmaceuticals·2026
Single-Cell Transcriptomics in Triple-Negative Breast Cancer: Implications for Radionuclide Therapy in Precision Oncology.
Cancer biotherapy & radiopharmaceuticals·2026
Curved Vertebroplasty System Combined with Targeted Radionuclide Therapy for Tumor-Related Pathological Vertebral Fractures.
Cancer biotherapy & radiopharmaceuticals·2026